Efficacy and Safety of 1-Month Postpartum Zidovudine-Didanosine to Prevent HIV-Resistance Mutations after Intrapartum Single-Dose Nevirapine
Clicks: 128
ID: 112551
2010
Article Quality & Performance Metrics
Overall Quality
Improving Quality
0.0
/100
Combines engagement data with AI-assessed academic quality
Reader Engagement
Emerging Content
0.3
/100
1 views
1 readers
Trending
AI Quality Assessment
Not analyzed
Abstract
Abstract. Background. Intrapartum single-dose nevirapine plus third trimester maternal and infant zidovudine are essential components of programs to prevent mo| Reference Key |
marc2010clinicalefficacy
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lallemant, Marc;Ngo-Giang-Huong, Nicole;Jourdain, Gonzague;Traisaithit, Patrinee;Cressey, Tim R.;Collins, Intira J.;Jarupanich, Tapnarong;Sukhumanant, Thammanoon;Achalapong, Jullapong;Sabsanong, Prapan;Chotivanich, Nantasak;Winiyakul, Narong;Ariyadej, Surabon;Kanjanasing, Annop;Ratanakosol, Janyaporn;Hemvuttiphan, Jittapol;Kengsakul, Karun;Wannapira, Wiroj;Sittipiyasakul, Veerachai;Pornkitprasarn, Witaya;Liampongsabuddhi, Prateung;McIntosh, Kenneth;Van Dyke, Russell B.;Frenkel, Lisa M.;Koetsawang, Suporn;Coeur, Sophie Le;Kanchana, Siripon;for the PHPT-4 Study Team; |
| Journal | clinical infectious diseases |
| Year | 2010 |
| DOI | DOI not found |
| URL | |
| Keywords |
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.